Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups

por Ailawadhi, S, Swaika, A, Razavi, P, Yang, D, Chanan-Khan, A
Publicado 2014

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma

por Chanan-Khan, A A, Swaika, A, Paulus, A, Kumar, S K, Mikhael, J R, Rajkumar, S V, Dispenzieri, A, Lacy, M Q
Publicado 2013